You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSB0010718C

Showing 1 - 25 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • (no location specified)
Jul 13, 2023

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

Active, not recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Ballarat, Victoria, Australia
  • +2 more
Jan 30, 2023

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +3 more
  • Avelumab
  • +7 more
  • Danville, Illinois
  • +4 more
Jul 29, 2022

Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))

Active, not recruiting
  • Urothelial Carcinoma
  • MRx0518
  • Avelumab 20 mg/mL Intravenous Solution (IV)
  • Irvine, California
  • +2 more
Jul 5, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Los Angeles, California
  • +3 more
Aug 22, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)

Recruiting
  • Locally Advanced or Metastatic Urothelial Carcinoma
  • Coeur d'Alene, Idaho
  • +19 more
Oct 4, 2022

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)

Completed
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • London, United Kingdom
    University College London Hospital
Oct 1, 2021

Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)

Recruiting
  • Penile Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Rectal Cancer Trial in Melbourne (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jan 31, 2021

Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))

Completed
Has Results
  • Renal Cell Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Scottsdale, Arizona
  • +20 more
Dec 6, 2021

Cancer Trial in Germany (Avelumab)

Completed
  • Cancer
  • Halle (Saale), Germany
  • +3 more
Feb 24, 2022

Breast Cancer Trial in Philadelphia (HCQ, Avelumab, Palbociclib)

Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 26, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

NSCLC Trial in Worldwide (Avelumab, PF-06463922, Crizotinib)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Atlanta, Georgia
  • +20 more
Jan 13, 2022

Metastatic Solid Tumors Trial in Guangzhou, Changchun, Hangzhou (Avelumab)

Completed
  • Metastatic Solid Tumors
  • Guangzhou, Guangzhou, China
  • +2 more
May 12, 2021

Myeloma, Multiple, Myeloma-Multiple Trial run by the NCI (Avelumab, External beam radiotherapy)

Terminated
Has Results
  • Myeloma, Multiple
  • Myeloma-Multiple
  • Avelumab
  • External beam radiotherapy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2021

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Advanced Malignant Skin Tumor, Metastatic Malignant Skin Tumor Trial in Los Angeles (drug, biological, other)

Recruiting
  • Advanced Malignant Skin Neoplasm
  • Metastatic Malignant Skin Neoplasm
  • Los Angeles, California
  • +1 more
Apr 1, 2021